In an era when trademarks increasingly drive corporate growth we cannot agree on what they are worth
 

The modern letter X derives from the Semitic sign “samekh” and was the 15th letter in the original alphabetic sequence.

Twitter mogul Elon Musk has entered the swirling conversations about LeBron James’ son after the 18-year-

Musk has been talking a good game about wanting to build new things on top of the old Twitter.

One little letter, so much baggage.

One of the most recognisable logos on the web, the tweeting blue bird, is no more. Will the black and white X replacing it prove to be a masterstroke or a branding disaster?

In changing Twitter’s blue logo, owner Elon Musk is trading a bird in the hand for the promise of a wide-ranging “everything app" analysts say may never materialize

Billionaire owner posts image of flickering white “X” on black background though website hasn’t changed

Its ability to draw advertising support is, as yet, unproven

Twitter's website says its logo, depicting a blue bird, is "our most recognizable asset."

The fediverse allows users to connect and communicate with others seamlessly across multiple platforms

Latest sign that aggressive cost-cutting measures since Musk acquired Twitter are not enough to get cash flow positive

The newness of Threads has worn off, according to estimates of user data.

Former Fox News host and associate look to raise funds for new venture that could use Twitter as its backbone

Meta's new social network continues to break records, with the number of users approaching 100 million, even though the application isn't available in the European Union.

Threads is looking into adding an alternative home feed, of only posts, in chronological order, from the people each individual user follows, according to Instagram boss Adam Mosseri.

Analysts see Threads as first potential threat to Elon Musk-owned Twitter

Mark Zuckerberg’s rival social network is first serious threat to Twitter since Elon Musk takeover

A series of disastrous missteps over the past year has robbed Twitter of its relevance

Intas Pharmaceuticals in India made a widely used cancer drug in the U.S. An inspection exposed problems — and the fragility of the U.S. generic-drug supply.